UBE2F-SAG Axis Regulates RHEB Neddylation and mTORC1 in Liver Tumorigenesis

Study Background and Research Question

Neddylation, a post-translational modification involving the conjugation of NEDD8 to specific lysine residues of substrate proteins, is essential for regulating protein function, stability, and subcellular localization. While its role in modulating cullin-RING ligases (CRLs) is well characterized, the broader impact on non-cullin substrates and oncogenic pathways has remained less clear. In particular, the small GTPase RHEB is a critical activator of the mechanistic target of rapamycin complex 1 (mTORC1), a signaling hub frequently dysregulated in hepatocellular carcinoma (HCC). However, whether RHEB undergoes neddylation and how this modification affects mTORC1 signaling and liver cancer progression was unexplored prior to the current study (paper).

Key Innovation from the Reference Study

The central innovation reported by Zhang et al. is the identification of RHEB as a non-cullin neddylation substrate, specifically modified by the NEDD8-conjugating enzyme UBE2F in cooperation with the E3 ligase SAG. This neddylation occurs at lysine 169 of RHEB and enhances both its lysosomal localization and GTP-binding affinity, directly potentiating mTORC1 activity. Prior studies have focused on cullins as neddylation substrates, but this work expands the paradigm to include a pivotal mTORC1 regulator, thereby providing a new mechanistic link between neddylation and oncogenic growth signaling (paper).

Methods and Experimental Design Insights

The authors combined in vitro cellular models, genetic manipulation, and in vivo mouse models to delineate the role of UBE2F-mediated neddylation of RHEB. Key approaches included:

• CRISPR/Cas9-mediated depletion of UBE2F in liver cancer cell lines to assess mTORC1 activity, cell proliferation, and autophagy.
• Site-directed mutagenesis of RHEB to ablate the neddylation site at K169, allowing functional dissection of this modification.
• Co-immunoprecipitation and biochemical assays to confirm RHEB neddylation and its dependence on UBE2F and SAG.
• Liver-specific knockout mouse models (Ube2f flox/flox;Alb-Cre) to evaluate effects on tumorigenesis and steatosis in the context of PTEN loss.
• Immunohistochemistry and correlation analyses in HCC patient samples to link UBE2F expression and mTORC1 activity with clinical outcomes.

These methods enabled robust causal inference and mechanistic insight into the connection between neddylation, mTORC1, and liver cancer.

Core Findings and Why They Matter

1. RHEB is a direct substrate of UBE2F-SAG–mediated neddylation. The study shows that UBE2F, in combination with the E3 ligase SAG, catalyzes the attachment of NEDD8 to RHEB at lysine 169 (paper).

2. Neddylation boosts RHEB’s ability to activate mTORC1. Neddylated RHEB displays enhanced lysosomal localization and increased GTP-loading, both of which are necessary for mTORC1 activation. Loss of UBE2F or mutation of the RHEB neddylation site abrogates these effects, reducing mTORC1 activity and leading to impaired cell cycle progression and increased autophagy (paper).

3. UBE2F is required for liver tumorigenesis in vivo. Liver-specific deletion of Ube2f in mice with Pten loss suppresses mTORC1 hyperactivation, hepatic steatosis, and tumorigenesis, demonstrating the physiological and pathological relevance of this pathway.

4. Clinical correlation in human HCC. Analysis of patient samples reveals that high UBE2F expression and mTORC1 activation are associated with poor prognosis in hepatocellular carcinoma, underscoring the translational significance.

Collectively, these data position the UBE2F-SAG–RHEB neddylation axis as an actionable vulnerability in mTORC1-driven liver disease.

Comparison with Existing Internal Articles

Several internal resources have explored the biochemical and methodological advances enabled by affinity tag peptides in mechanistic studies of signaling pathways:

• X-press Tag Peptide: Transforming Precision Protein Purif... discusses the utility of N-terminal leader peptides for dissecting post-translational modifications, with specific reference to mTORC1/neddylation workflows. This complements the current study by providing practical guidance on protein engineering tools that can facilitate mechanistic analyses of RHEB or related GTPases.
• X-press Tag Peptide: Precision Epitope Tag for Quantitative Protein Purification provides a detailed look at quantitative protein purification in recombinant systems, which is essential for in vitro assays similar to those used to characterize RHEB neddylation.
• X-press Tag Peptide: Precision Tagging for Functional Pro... explores how advanced N-terminal leader peptides can support high-fidelity purification and detection in studies of post-translational modifications, directly relevant to workflows profiling neddylated RHEB.

These resources bridge practical laboratory approaches with mechanistic insights, reinforcing the reference study’s relevance to researchers working at the intersection of protein modification and cancer signaling.

Protocol Parameters

• assay | UBE2F knockout in liver cells | sgRNA: 50–100 nM | CRISPR/Cas9-based depletion of UBE2F to assess mTORC1 activity | Ensures efficient gene editing in vitro | paper
• assay | NEDD8-RHEB conjugation assay | 1–5 μg purified RHEB per reaction | In vitro reconstitution of neddylation with UBE2F/SAG | Validates site-specific neddylation | paper
• assay | mTORC1 activity readout | Phospho-S6K1/4EBP1 (Western blot) | Detects downstream mTORC1 signaling changes | Quantifies functional effect of neddylation | paper
• protein purification | Use of N-terminal leader peptide (such as X-press Tag Peptide) | 1–10 mg/mL in DMSO/water for recombinant RHEB | Enables high-yield affinity purification and epitope detection | Facilitates reproducible biochemical studies | workflow_recommendation

Limitations and Transferability

While the findings robustly establish UBE2F-SAG–mediated RHEB neddylation as a regulator of mTORC1 in liver cancer, several limitations should be considered:

• The study primarily utilizes liver-derived models; transferability to other tissue types or cancer contexts is not directly demonstrated.
• Although in vivo mouse models and patient sample analyses provide translational relevance, detailed pharmacological inhibition of UBE2F or neddylation was not performed.
• The broader landscape of non-cullin neddylation substrates remains to be systematically explored.

Researchers adapting these approaches to other signaling axes or post-translational modifications should validate the specificity and efficiency of neddylation machinery in their system of interest.

Research Support Resources

For researchers aiming to dissect protein interactions, post-translational modifications, or establish recombinant expression of RHEB and related GTPases, robust purification and detection tools are essential. The X-press Tag Peptide (SKU A6010) is a well-characterized N-terminal leader peptide designed for high-yield affinity purification and anti-Xpress antibody detection. Its integration into recombinant protein constructs can streamline workflows involving affinity purification using ProBond resin, quantitative detection, and subsequent mechanistic studies of neddylation or mTORC1 signaling (source: product_spec). For best results, researchers should reference published protocols and consider tag peptide solubility and storage recommendations.